Back to Journals » Infection and Drug Resistance » Volume 12

Corrigendum

A Comparison Between Dexlansoprazole Modified Release–Based And Lansoprazole-Based Nonbismuth Quadruple (Concomitant) Therapy For First-Line Helicobacter pylori Eradication: A Prospective Randomized Trial [Corrigendum]

       

Authors Tai WC , Liang CM , Bi KW , Kuo CM, Lu LS, Wu CK , Yang SC, Kuo YH, Lee CH, Huang CF , Hsu CN , Hsu PI, Wu DC , Hu TH, Wu KL , Chuah SK 

Received 19 September 2019

Accepted for publication 19 September 2019

Published 25 September 2019 Volume 2019:12 Pages 3049—3050

DOI https://doi.org/10.2147/IDR.S231699

Download Article [PDF] 


Tai WC, Liang CM, Bi KW, et al. Infect Drug Resist.

2019;12:2923–2931.

Following a review of our paper post-publication, we found under the ethics approval and informed consent section on page 2929, the IRB number is incorrect. The correct statement is “This study’s protocol was approved by the institutional review board and the ethics committee of Chang Gung Memorial Hospital (IRB 201601061A3)”. The authors apologize for this error.

Read the original article

Creative Commons License © 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]